Stemline Therapeutics reported -0.450 in EPS Earnings Per Share for its first quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Abbvie U$ 0.002K 0K
Agenus -0.028 0.003
Amgen U$ 4.2500 0.0800
Aptinyx Inc -0.027 0.007
Arena Pharmaceuticals -0.161 0.039
Astellas Pharma Y 27.1400 23.9500
Biocryst Pharmaceuticals -0.024 0
Bristol Myers Squibb U$ 1.6300 0.0900
Celgene U$ 2.9900 0.1300
Celldex Therapeutics -0.05 0.023
Daiichi Sankyo Y 16.3830 19.0630
Eisai Y 85.2280 84.1020
Geron -0.006 0.002
GlaxoSmithKline 0.1920 0.1820
Halozyme Therapeutics U$ 0.1900 0.2300
Immunogen -0.014 0.003
Intra Cellular Therapies -0.096 0.023
JAZZ PHA U$ 4.3100 0.6000
Johnson & Johnson 2.2000 0.5300
Karyopharm Therapeutics -0.063 0.015
Macrogenics -0.094 0.003
Merk U$ 1.3700 0.1300
Novartis SF 1.3600 0.2000
Pfizer U$ 0.7800 0.0200
Sanofi € 1.2800 0.3500
Seattle Genetics U$ -0.1200 0.8600
Stemline Therapeutics -0.045 0.007
Sumitomo Dainippon Y 45.9600 54.0800
Sunesis Pharmaceuticals -0.06 0.01
Tg Therapeutics -0.047 0.001
United Therapeutics U$ 2.4100 0.7100
Verastem -0.014 0.021
Vital Therapies U$ -0.9000 0.1100